Abstract:The photoactivatable PROTACs‐Like (paProtacL) target protein via nanobodies and can controllably induce degradation of POI (protein of interest) under blue light. The photoactivatable Cas9 (paCas9) system can edit GOI (gene of interest) in the nucleus in a controlled manner under blue light irradiation. When paProtacL is combined with the paCas9 system, it can minimize the expression of the target protein. Background Precise regulation of partial critical proteins in cancer cells, such as anti‐apoptotic proteins, is one of the crucial strategies for treating cancer and discovering related molecular mechanisms. Still, it is also challenging in actual research and practice. The widely used CRISPR/Cas9‐based gene editing technology and proteolysis‐targeting chimeras (PROTACs) have played an essential role in regulating gene expression and protein function in cells. However, the accuracy and controllability of their targeting remain necessary. Methods Construction of UMUC‐3‐EGFP stable transgenic cell lines using the Sleeping Beauty system, Flow cytometry, quantitative real‐time PCR, western blot, fluorescence microplate reader and fluorescence inverted microscope analysis of EGFP intensity. Characterization of Survivin inhibition was done by using Annexin V‐FITC/PI apoptosis, calcein/PI/DAPI cell viability/cytotoxicity assay, cloning formation assay and scratch assay. The cell‐derived xenograft (CDX) model was constructed to assess the in vivo effects of reducing Survivin expression. Results Herein, we established a synergistic control platform that coordinated photoactivatable split‐Cas9 targeted gene editing and light‐induced protein degradation, on which the Survivin gene in the nucleus was controllably edited by blue light irradiation (named paCas9‐Survivin) and simultaneously the Survivin protein in the cytoplasm was degraded precisely by a nanobody‐mediated target (named paProtacL‐Survivin). Meanwhile, in vitro experiments demonstrated that reducing Survivin expression could effectively promote apoptosis and decrease the proliferation and migration of bladder cancerous cells. Furthermore, the CDX model was constructed using UMUC‐3 cell lines, results from animal studies indicated that both the paCas9‐Survivin system and paProtacL‐Survivin significantly inhibited tumour growth, with higher inhibition rates when combined. Conclusions In short, the coordinated regulatory strategies and combinable technology platforms offer clear advantages in controllability and targeting, as well as an excellent reference value and universal applicability in controlling the fate of cancer cells through multi‐level regulation of key intracellular factors.

Comparison of Caspase Genes for the Induction of Apoptosis Following Gene Delivery

Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo.

[Expression of Caspase Apoptosis Pathway Genes Mrna in Colorectal Cancer and Polyps].

Synergistic Apoptotic Effect of Crocin and Cisplatin on Osteosarcoma Cells Via Caspase Induced Apoptosis.

Cell-to-cell Variability in Inducible Caspase9-mediated Cell Death

Antitumor Potential of SLPI Promoter Controlled Recombinant Caspase-3 Expression in Laryngeal Carcinoma

Combining caspase and mitochondrial dysfunction inhibitors of apoptosis to limit cell death in mammalian cell cultures

Influence of Apoptin on Up-Regulation of the Expression of Bad and Bax

Efficient Gene Transfection into Mammalian Cells Mediated by Cross-linked Polyethylenimine

Caspase expression profile and functional activity in a panel of breast cancer cell lines.

Caspase-3 Mediated Feedback Activation of Apical Caspases in Doxorubicin and TNF-α Induced Apoptosis

Apoptotic Effects of the Exogenous PTEN Tumor Suppressor Gene on Human Mucoepidermoid Carcinoma Cell Line

Generation of Constitutively Active Recombinant Caspases-3 and -6 by Rearrangement of Their Subunits

Combination of Caspy2 and IP-10 Gene Therapy Significantly Improves Therapeutic Efficacy Against Murine Malignant Neoplasm Growth and Metastasis.

A Novel Strategy for Tumour Therapy Combining Cell Apoptosis and Active Immunity Induced by Caspy2, a Zebrafish Caspase

INDUCTION OF APOPTOSIS IN BPH STROMAL CELLS BY ADENOVIRAL-MEDIATED OVEREXPRESSION OF CASPASE-7

Visualization of Caspase-3-like Activity in Cells Using a Genetically Encoded Fluorescent Biosensor Activated by Protein Cleavage

Delivery of Mixed-Lineage Kinase Domain-Like Protein by Vapor Nanobubble Photoporation Induces Necroptotic-Like Cell Death in Tumor Cells

Expression Andin Vitrocleavage Activity of Anti-Caspase-7 Hammerhead Ribozymes

Split‐Cas9‐based targeted gene editing and nanobody‐mediated proteolysis‐targeting chimeras optogenetically coordinated regulation of Survivin to control the fate of cancer cells

Development of an inducible caspase-9 safety switch for pluripotent stem cell–based therapies